- Home
- ARVN
ARVN
Arvinas Inc.
as of 12-10-2025 4:00pm EST
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 806.0M | IPO Year: | 2018 |
| Target Price: | $17.80 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 23 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $25.75 | Next Earning Date: | 11-05-2025 |
| Revenue: | $312,300,000 | Revenue Growth: | 93.86% |
| Revenue Growth (this year): | 11.06% | Revenue Growth (next year): | -67.28% |
AI-Powered ARVN Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Arvinas Inc. (ARVN)
Chief Accounting Officer
Avg Cost/Share
$9.89
Shares
230
Total Value
$2,274.70
Owned After
31,697
SEC Form 4
Director
Avg Cost/Share
$7.57
Shares
30,000
Total Value
$227,010.00
Owned After
76,021
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Loomis David K | ARVN | Chief Accounting Officer | Nov 7, 2025 | Sell | $9.89 | 230 | $2,274.70 | 31,697 | |
| Morrison Briggs | ARVN | Director | Sep 22, 2025 | Buy | $7.57 | 30,000 | $227,010.00 | 76,021 |
Compare ARVN vs Leading Stocks
See how ARVN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ARVN Arvinas Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.